CIK 0001213037
- Non-accelerated filer
- Smaller reporting company
Cardiff Oncology, Inc.
Sign in to watch- Ticker
- CRDF
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272004382
- Phone
- +1 858-952-7570
- Business address
- 11055 FLINTKOTE AVENUE, SAN DIEGO, CA, 92121
- Former names
- Trovagene, Inc., TrovaGene Inc., XENOMICS INC, USED KAR PARTS INC
- 4 Open-market buy Director bought 15,000 shares at $1.64 ($24,525)
- 4 Open-market buy Director bought 10,000 shares at an average $1.72 ($17,168)
- 4 Open-market buy Director bought 150,000 shares at $1.71 ($256,500)
- 4 Open-market buy Chief Financial Officer bought 30,000 shares at $1.56 ($46,710)
- 4 Option exercise Director acquired 28,858 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 30,000 shares at $6.75 ($202,500)
- 4 Open-market buy Chief Financial Officer bought 30,000 shares at an average $6.47 ($194,000)
Page 4 of 15 · 300 filings